Applications from the field of Pharma & Biopharma focused on ICP/MS | LabRulez ICPMS

Culture Medium Analysis for a Metabolic Analysis of Antibody-Producing Cells Using LC-MS/MS and ICP-MS

Applications

| 2023 | Shimadzu

LC/MS, LC/MS/MS, LC/QQQ, ICP/MS

Instrumentation

LC/MS, LC/MS/MS, LC/QQQ, ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Analysis of ICH Q3D Guideline for Elemental Impurities in Drug Products Using ICPMS-2030

Applications

| 2016 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

WCPS: Analysis of Metal Impurities in Pharmaceutical Ingredients in Preparation for the New USP Methods

Posters

| 2011 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Artificial Tear Eye Drops For Elemental Impurities

Applications

| 2022 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Measuring Elemental Impurities in Pharmaceutical Materials

Brochures and specifications

| 2022 | Agilent Technologies

Consumables, ICP/MS, ICP/OES

Instrumentation

Consumables, ICP/MS, ICP/OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)

Applications

| 2022 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES

Applications

| 2020 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-MS Solution

Technical notes

| 2021 | Agilent Technologies

Software, HPLC, ICP/MS, Speciation analysis

Instrumentation

Software, HPLC, ICP/MS, Speciation analysis

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of elemental impurities in pharmaceutical products in accordance with USP General Chapters <232> and <233>

Applications

| 2022 | Thermo Fisher Scientific

ICP/MS, ICP/OES

Instrumentation

ICP/MS, ICP/OES

Manufacturer

Thermo Fisher Scientific

Industries

Pharma & Biopharma

Analysis of Toxic Elements in Supplements as per USP 2232 Using the ICPMS-2030

Applications

| 2016 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Applications from the field of Pharma & Biopharma focused on ICP/MS | LabRulez ICPMS

Culture Medium Analysis for a Metabolic Analysis of Antibody-Producing Cells Using LC-MS/MS and ICP-MS

Analysis of ICH Q3D Guideline for Elemental Impurities in Drug Products Using ICPMS-2030

WCPS: Analysis of Metal Impurities in Pharmaceutical Ingredients in Preparation for the New USP Methods

Analysis of Artificial Tear Eye Drops For Elemental Impurities

Measuring Elemental Impurities in Pharmaceutical Materials

Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)

Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES

USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-MS Solution

Analysis of elemental impurities in pharmaceutical products in accordance with USP General Chapters <232> and <233>

Analysis of Toxic Elements in Supplements as per USP 2232 Using the ICPMS-2030

Related content

From a scientific project to a global business venture. The company mzio is striving to improve data analysis in mass spectrometry labs

Cryo-EM structures show how Trypanosomes escape the human innate immune response

An innovative approach to planar chiral substances